Your browser doesn't support javascript.
loading
Qué debe saber el médico de familia sobre el trasplante pulmonar. Complicaciones, promoción de la salud y supervivencia (Parte 2) / What the family doctor must know about lung transplantation. Complications, health promotion, and outcomes (Part 2)
Zurbano, L; Zurbano, F.
Affiliation
  • Zurbano, L; Hospital Universitario Marqués de Valdecilla. Servicio de Neumología. Unidad de Trasplante Pulmonar. Santander. España
  • Zurbano, F; Hospital Universitario Marqués de Valdecilla. Servicio de Neumología. Unidad de Trasplante Pulmonar. Santander. España
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.) ; 43(7): 511-518, oct. 2017. ilus, tab
Article in Spanish | IBECS | ID: ibc-168729
Responsible library: ES1.1
Localization: BNCS
RESUMEN
El trasplante pulmonar es un procedimiento terapéutico, médico-quirúrgico, indicado en enfermedades pulmonares terminales e irreversibles con los tratamientos médicos actuales, excepto el carcinoma pulmonar. Es un tratamiento emergente en atención médica. En esta revisión se analizan las complicaciones más frecuentes del trasplante pulmonar relacionadas con el injerto (rechazo y disfunción crónica); la inmunosupresión (infecciones, hipertensión arterial, diabetes, etc.); otras especialmente frecuentes (gastrointestinales, osteoporosis, etc.) y la actitud terapéutica más razonable. Se especifican los controles a realizar para vigilar la evolución del injerto y del paciente, las recomendaciones generales para la consecución de un estilo de vida saludable y de la mayor calidad posible y la supervivencia tanto del registro español como del registro internacional, su evolución histórica y las causas más frecuentes de muerte, para poder así analizar la utilidad real del trasplante (AU)
ABSTRACT
The lung transplantation is a therapeutic procedure indicated for lung diseases that are terminal and irreversible (except lung cancer) despite the best medical current treatment. It is an emergent procedure in medical care. In this review, an analyse is made of the most frequent complications of lung transplant related to the graft (rejection and chronic graft dysfunction), immunosuppression (infections, arterial hypertension, renal dysfunction, and diabetes), as well as others such as gastrointestinal complications, osteoporosis. The most advisable therapeutic options are also included. pecific mention is made of the reviews and follow-up for monitoring the graft and the patients, as well as the lifestyle recommended to improve the prognosis and quality of life. An analysis is also made on the outcomes in the Spanish and international registries, their historical evolution and the most frequent causes of death, in order to objectively analyse the usefulness of the transplant (AU)
Subject(s)

Full text: Available Collection: National databases / Spain Health context: SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Endocrine System Diseases Database: IBECS Main subject: Lung Transplantation / Cytomegalovirus Infections / Graft Rejection / Immunosuppressive Agents Type of study: Practice guideline / Prognostic study Aspects: Patient-preference Limits: Humans Language: Spanish Journal: SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.) Year: 2017 Document type: Article Institution/Affiliation country: Hospital Universitario Marqués de Valdecilla/España

Full text: Available Collection: National databases / Spain Health context: SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Endocrine System Diseases Database: IBECS Main subject: Lung Transplantation / Cytomegalovirus Infections / Graft Rejection / Immunosuppressive Agents Type of study: Practice guideline / Prognostic study Aspects: Patient-preference Limits: Humans Language: Spanish Journal: SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.) Year: 2017 Document type: Article Institution/Affiliation country: Hospital Universitario Marqués de Valdecilla/España
...